Sec Form 4 Filing - CONCANNON BRIAN @ HAEMONETICS CORP - 2013-08-01

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
CONCANNON BRIAN
2. Issuer Name and Ticker or Trading Symbol
HAEMONETICS CORP [ HAE]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
President & CEO
(Last) (First) (Middle)
400 WOOD ROAD
3. Date of Earliest Transaction (MM/DD/YY)
08/01/2013
(Street)
BRAINTREE, MA02184
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/01/2013 M 3,000 ( 1 ) A $ 13.0525 118,798 ( 2 ) D
Common Stock 08/01/2013 S 3,000 ( 1 ) D $ 42.3 115,798 ( 2 ) D
Common Stock 08/01/2013 M 10,000 ( 1 ) A $ 11.3175 125,798 ( 2 ) D
Common Stock 08/01/2013 S 10,000 ( 1 ) D $ 42.2244 115,798 ( 2 ) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities B eneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $ 11.3175 08/01/2013 M 10,000 09/15/2004( 3 ) 09/15/2013 Common Stock 10,000 $ 42.23 10,000 D
Non-Qualified Stock Option (right to buy) $ 13.0525 08/01/2013 M 3,000 05/05/2005( 3 ) 05/05/2014 Common Stock 3,000 $ 42.3 18,000 D
Non-Qualified Stock Option (right to buy) $ 25.535 10/24/2008( 3 ) 10/24/2014 Common Stock 45,780 45,780 D
Non-Qualified Stock Option (right to buy) $ 26.47 10/27/2010( 3 ) 10/27/2016 Common Stock 159,350 159,350 D
Non-Qualified Stock Option (right to buy) $ 27.275 10/22/2009( 3 ) 10/22/2015 Common Stock 57,176 57,176 D
Non-Qualified Stock Option (right to buy) $ 27.495 10/27/2011( 3 ) 10/27/2017 Common Stock 236,750 236,750 D
Non-Qualified Stock Option (right to buy) $ 27.685 04/02/2010( 3 ) 04/02/2016 Common Stock 65,690 65,690 D
Non-Qualified Stock Option (right to buy) $ 30.67 10/25/2012( 3 ) 10/25/2018 Common Stock 219,572 219,572 D
Non-Qualified Stock Option (right to buy) $ 39.055 10/24/2013( 3 ) 10/24/2019 Common Stock 250,382 250,382 D
Performance Shares $ 0 03/31/2017( 4 ) 12/31/2017( 4 ) Common Stock 50,000 50,000 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
CONCANNON BRIAN
400 WOOD ROAD
BRAINTREE, MA02184
X President & CEO
Signatures
By: Alexander Steffan For: Brian Concannon 08/05/2013
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Pursuant to a 10b5-1 Plan.
( 2 )Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
( 3 )Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
( 4 )Market Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Market Stock Unit based on Haemonetics stock price during the 30 trading days prior to March 31, 2017. The number of Market Stock Units (and therefore the number of shares payable) will depend on the Companys stock price during such period. The Market Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to three times the target amount in column 5. The Market Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d).

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.